Evogene annual operating margin
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Evogene Operating Margin Growth & History (EVGN)
Evogene's operating margin was −364.24% for fiscal 2025.
View full Evogene company overviewEvogene annual operating margin history
| Fiscal year | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | −364.24% | −27.07 pp |
| 2024 | 2024-12-31 | −337.17% | +408.34 pp |
| 2023 | 2023-12-31 | −745.51% | +862.91 pp |
| 2022 | 2022-12-31 | −1,608.42% | +1719.86 pp |
| 2021 | 2021-12-31 | −3,328.28% | −942.32 pp |
| 2020 | 2020-12-31 | −2,385.96% | +424.93 pp |
| 2019 | 2019-12-31 | −2,810.89% | −1666.70 pp |
| 2018 | 2018-12-31 | −1,144.19% | −495.06 pp |
| 2017 | 2017-12-31 | −649.13% | −326.67 pp |
| 2016 | 2016-12-31 | −322.46% | −161.43 pp |
| 2015 | 2015-12-31 | −161.03% | — |
Evogene quarterly operating margin
No reported data
| Fiscal quarter | Period ended | Operating margin | Change (percentage points) |
|---|
Evogene operating margin trends
Over the last five reported fiscal years, Evogene's operating margin increased from −2,385.96% to −364.24%, a change of +2021.73 percentage points.
About the metric
What operating margin means
Operating margin measures the percentage of revenue left after operating costs and expenses. It shows how much operating profit a company generates from each dollar of revenue.
Calculation and source
How operating margin is calculated
TickerStat calculates operating margin as SEC-reported operating income divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Evogene filings at SEC.gov ↗